单克隆抗体治疗患者行脊髓麻醉:一例警示性病例报告
本文报告一例68岁男性在接受奥妥珠单抗治疗滤泡性淋巴瘤期间,于脊髓麻醉下行经尿道前列腺电切术后出现截瘫和感觉减退,急诊MRI诊断为急性横贯性脊髓炎。既往奥妥珠单抗治疗后曾有类似但较轻的神经系统症状,提示该药可能是致病因素。高剂量类固醇治疗部分缓解症状,但术后3个月仍遗留致残性感觉减退和运动功能障碍。
要点
- 单克隆抗体治疗患者行椎管内麻醉需警惕罕见但严重的神经并发症。
- 奥妥珠单抗可能关联急性横贯性脊髓炎,既往神经系统症状史是重要线索。
- 术后新发截瘫需紧急MRI评估,高剂量类固醇可能部分缓解但未必完全恢复。
核心结论
- 对正在接受单克隆抗体治疗的患者实施椎管内麻醉应谨慎。
研究设计与样本
- 病例报告:一例68岁男性脊髓麻醉下经尿道前列腺电切术后出现截瘫和感觉减退。
主要发现
- 急诊MRI诊断为急性横贯性脊髓炎。
- 既往奥妥珠单抗治疗后有类似但较轻的神经系统症状。
- 高剂量类固醇治疗后症状部分缓解,术后3个月仍遗留致残性感觉减退和运动功能障碍。
临床怎么用
- 椎管内麻醉前应详细询问单克隆抗体治疗史及既往神经系统症状。
- 术后出现神经功能缺损应紧急行MRI并考虑急性横贯性脊髓炎。
局限性
- 单例病例报告,因果关系不能确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Paraplegia is a rare complication of spinal anesthesia. CASE PRESENTATION: We report a case of a 68-year-old man who developed postoperative paraplegia and hypoesthesia after spinal anesthesia for an otherwise uncomplicated transurethral resection of the prostate. Acute transverse myelitis was diagnosed based on urgent MRI. A prior history of similar though less severe neurological symptoms after obinutuzumab treatment for follicular lymphoma suggested a potential causative role for obinutuzumab, a novel monoclonal antibody that has not been associated with such devastating neurological side effects yet. High-dose steroid treatment partially attenuated the symptoms, but debilitating hypoesthesia and motor deficit remained present 3 months postoperatively. CONCLUSION: The presented case warrants caution when performing neuraxial anesthesia in patients on monoclonal antibody therapies.
引用
- Herijgers A, Van Dyck L, Leroy I, et al. Spinal anesthesia in a patient on monoclonal antibody treatment: a poisoned chalice? A case report. Reg Anesth Pain Med. 2021. PMID: 33875579. doi:10.1136/rapm-2021-102557
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。